Facebook
Twitter
LinkedIn
ForwardEchocardiography and Noninvasive Vascular Testing Lecture Series: Multimodality Imaging in the Setting of COVID 19: Case Based Discussions
COVID-19 is a complex, multisystem disease, which can have profound effects on many parts of the body, including the heart. The medical literature documents that approximately half of COVID-19 patients who received an echocardiogram in-hospital showed abnormalities in heart function. Some prospective studies found that around one in seven showed severe abnormalities likely to have a major effect on their survival and recovery.
This lecture will review cases that detail the patient selection process and test findings that strongly guide disease management.
Target Audience
Cardiologists, vascular surgeons, interventional radiologists, echocardiography and noninvasive vascular testing specialists, nurses, sonographers, pharmacists, respiratory technologists
Learning Objectives
- Recognize the cardiac pathophysiology commonly seen in patients with COVID-19.
- Determine the appropriate indications for when to test for COVID-19.
- Demonstrate when to apply proper echocardiography protocol.
- Appropriately interpret the findings to guide disease management.
Elliott J. Elias, M.D., MPH, FACC, FASE
Cardiologist
Medical Director of Cardiac and Structural Imaging
Baptist Health Medical Group
Baptist Health Quality Network
Miami Cardiac & Vascular Institute at Baptist Hospital of Miami and West Kendall Baptist Hospital
Miami, Florida
Sandra Chaparro, M.D., FACC
Director, Advanced Heart Failure
Miami Cardiac & Vascular Institute
Baptist Health South Florida
Jonathan Dunn, M.D.
Cardiologist, Baptist Health Quality Network
Baptist Health South Florida
Karl Sayegh, M.D.
Diagnostic Radiologist, Baptist Health Quality Network
Baptist Health South Florida
Marcus St. John, M.D., FACC, FSCAI
Medical Director, Cardiac Catheterization Lab
Miami Cardiac & Vascular Institute
Baptist Health South Florida
Elliott J. Elias, M.D., disclosed that he is a member of the speaker’s bureau for Abbott Laboratories, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Sandra Chaparro, M.D., has no relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in her presentation or discussion.
Jonathan Dunn, M.D., has no relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation or discussion.
Dr. Karl Sayegh, M.D., has no relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation or discussion.
Marcus St. John, M.D., has no relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation or discussion.
Planning Group Disclosures
Muhammad Hasan, MBBCh, RPVI, indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will include off-label or unapproved product usage in his presentation(s) or discussion(s).Planning Group Disclosures
Elliott J. Elias, M.D., disclosed that he is a member of the speakers bureau for Abbott Laboratories, and his participation will not include discussion of off-label or unapproved product usage.
Brian J. Schiro, M.D., disclosed that he receives grant/research support from Medtronic and the he is a member of the speaker’s bureau for Penumbra and Sirtex. Dr. Schiro has also disclosed that his lecture will include discussion of off-label or unapproved usage.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have relevant financial relationships to disclose.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 1 credit hour, CE Broker Course #20-716239, by the Florida Boards of Medicine, Osteopathic Medicine and by the Florida Council of Physician Assistants.
This activity has also been approved for 1 credit hour for Nurse Practitioners, Nurses, Pharmacists and Respiratory Therapists. Baptist Health South Florida CE Broker Provider #50-182.
American Registry for Diagnostic Medical Sonography - Sonographers and vascular technologists may use these credits to fulfill their ARDMS requirements. The ARDMS accepts AMA PRA Category 1 Credits™.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Pharmacy
- 1.00 Florida Board of Respiratory Therapy
Required Hardware/Software
 | PC/Mac UsersThis site is supported on the most recent stable releases of the following browsers:
| ||||||
 | Mobile UsersThis site is supported on the following mobile devices:
| ||||||
 | Technical SupportIf you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours. |
